Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fish Oil Firms Float Toxicology Work, Plot Media Blitz To Fight PCB Suit

This article was originally published in The Tan Sheet

Executive Summary

Fish oil supplement manufacturers will rely on science and strategic public relations to counter a California lawsuit alleging high levels of undisclosed contaminants in their products

You may also be interested in...



“Devil Is In The Details” On Prop 65 Reform Benefits – AHPA

California Governor Jerry Brown proposes to tweak Proposition 65 to reduce the number of frivolous lawsuits against small businesses. More than 10% of Prop 65 litigation targets since 2008 have been supplement firms, says the American Herbal Products Association.

Will The Rising Tide Of Rx Omega-3s Float The Fish Oil Supplement Market?

Omega-3 fish oils, once exclusive to the realm of dietary supplements, increasingly are swimming upstream into prescription drugs – a trend with both positive and negative implications for supplements.

Will The Rising Tide Of Rx Omega-3s Float The Fish Oil Supplement Market?

Omega-3 fish oils, once exclusive to the realm of dietary supplements, increasingly are swimming upstream into prescription drugs – a trend with both positive and negative implications for supplements.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103917

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel